Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 1161 - 1168 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCC5322 | Hematoxylin |
|
Hematoxylin and eosin (H+E) are pigments, they are used to morphological assessment.
|
|
| BCC5324 | Hypoxanthine |
|
Hypoxanthine, a purine derivative, is a potential free radical generator and could be used as an indicator of hypoxia.Hypoxanthine inhibits mouse oocyte maturation, it plays a role in vivo in maintaining meiotic arrest.
|
|
| BCC5325 | 9-Hydroxycalabaxanthone hydrate |
|
The combination of 9-hydroxycalabaxanthone with α-mangostin showed the synergistic antimalarial interaction in both clones.
|
|
| BCC5329 | DMH-1 |
|
Selective inhibitor of the bone morphogenic protein (BMP) ALK2 receptor (IC<sub>50</sub> = 108 nM). Exhibits no detectable inhibition of AMPK, ALK5, KDR (VEGFR-2) or PDGFR<span class='symbol'>β</span> receptors. Blocks BMP4-induced phosphorylation of Smads 1, 5 and 8 in HEK293 cells. Promotes neurogenesis in human induced pluripotent stem cells (iPSCs) when used in combination with SB 431542.
|
|
| BCC5331 | ML347 |
|
Potent and selective ALK2 and ALK1 inhibitor (IC50 values are 32 and 46 nM, respectively); displays >200 fold selectivity over ALK3 and ALK6 and >400 fold selectivity over VEGF2. Exhibits no activity at ALK4, ALK5 or in a panel of related kinases. Inhibits BMP4 signaling in a functional assay (IC50 = 152 nM).
|
|
| BCC5333 | (Z)-Pugnac |
|
<em>O</em>-GlcNAc-<span class='symbol'>β</span>-<em>N</em>-acetylglucosaminidase (<em>O</em>-GlcNAcase) and <span class='symbol'>β</span>-hexosaminidase inhibitor (K<sub>i</sub> values are 46 and 36 nM respectively) that increases <em>O</em>-GlcNAc levels ~ 2-fold in HT29 cells. <em>Z</em>-linked isomer is more potent than the <em>E</em> isomer.
|
|
| BCC5336 | (Arg)9 peptide |
|
(Arg)9 peptide is a cell-permeable peptide used for drug delivery.
|
|
| BCC5337 | 4EGI-1 |
|
Inhibitor of eIF4E:eIF4G interaction; prevents eIF4E binding to eIF4G. Binds eIF4E and inhibits cap-dependent translation but not initiation factor-independent translation. Exhibits activity against Jurkat and A549 cells.
|
|